Menu Search
Equities

Rxsight Inc

RXST:NMQ

Rxsight Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)44.83
  • Today's Change-0.22 / -0.49%
  • Shares traded540.54k
  • 1 Year change+57.13%
  • Beta1.1213
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Rxsight Inc grew revenues 81.77% from 49.01m to 89.08m while net income improved from a loss of 66.76m to a smaller loss of 48.61m.
Gross margin68.44%
Net profit margin-23.92%
Operating margin-30.46%
Return on assets-12.47%
Return on equity-13.99%
Return on investment-13.62%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Rxsight Inc fell by 2.19m. Cash Flow from Financing totalled 61.52m or 69.07% of revenues. In addition the company used 41.59m for operations while cash used for investing totalled 22.13m.
Cash flow per share-0.7019
Price/Cash flow per share--
Book value per share6.89
Tangible book value per share6.89
More ▼

Balance sheet in USDView more

Rxsight Inc uses little debt in its capital structure as supported by a debt to capital ratio of 0.05%.
Current ratio12.67
Quick ratio11.71
Total debt/total equity0.0005
Total debt/total capital0.0005
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 40.26%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		51.20
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.